Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-47,934
Closed -$3.68M 663
2022
Q1
$3.68M Buy
47,934
+20,875
+77% +$1.5M 0.01% 305
2021
Q4
$2.07M Sell
27,059
-5,989
-18% -$440K 0.01% 324
2021
Q3
$2.44M Buy
+33,048
New +$2.48M 0.01% 315
2020
Q4
Sell
-33,911
Closed -$2.25M 478
2020
Q3
$2.25M Sell
33,911
-8,386
-20% -$531K 0.01% 228
2020
Q2
$2.41M Buy
+42,297
New +$2.08M 0.01% 199

Other funds holding HOLX

Brookfield Corp's HOLX Position: Q2 2022 in Review

Brookfield Corp sold out of Hologic (HOLX) in Q2 2022, closing a stake of 47,934 shares — an estimated $3.68M sold.

Brookfield Corp first reported a position in HOLX in Q2 2020 and held it in 5 quarters. The position peaked at $3.68M in Q1 2022. 693 funds tracked by Wall St. Rank hold HOLX as of Q2 2022.

  • Brookfield Corp reported no remaining Hologic position as of Q2 2022 after selling out during the quarter.
  • Brookfield Corp sold 47,934 Hologic shares in Q2 2022, an estimated $3.68M.
  • Brookfield Corp first reported a position in Hologic in Q2 2020 and held it in 5 quarters.
  • Brookfield Corp's Hologic position peaked at $3.68M in Q1 2022.
  • 693 funds tracked by Wall St. Rank held Hologic as of Q2 2022.

Based on Brookfield Corp's 13F filing for Q2 2022, filed 15 Aug 2022.